91-105 of 2842
James Swanson, PhD
Bridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Conversations in CV Risk AssessmentBridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Jennifer Caudle, DO, FACOFP
Dustin Le, MD, MHS
Niloo Nobakht, MD, FASN
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Heart MattersEarly Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Valmiki Maharaj, MD
Ronald Witteles, MD
Nutritional Strategies for Inflammatory Balance and Immune Readiness
NutritionEdgeNutritional Strategies for Inflammatory Balance and Immune Readiness
Steve Jackson, PharmD
Cassie Smith, MD
Maria Gkini, MD, MSc, PhD
- advertisement
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
On the Frontlines of ATTR-CMEarly Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Shelina Ramnarine, PhD
Valmiki Maharaj, MD
Recognizing ATTR-CM in High-Risk Populations
On the Frontlines of ATTR-CMRecognizing ATTR-CM in High-Risk Populations
Steve Jackson, PharmD
Frederick Ruberg, MD
Evaluating Biologic Therapy Response in Severe Asthma Care
Clinician's RoundtableEvaluating Biologic Therapy Response in Severe Asthma Care
Charles Turck, PharmD, BCPS, BCCCP
Sara Assaf, MD
Rising Colorectal Cancer in Young Adults: Implications for Screening
Clinician's RoundtableRising Colorectal Cancer in Young Adults: Implications for Screening
Christopher Cann, MD
Understanding the Mechanisms Behind Resistant Hypertension
Heart MattersUnderstanding the Mechanisms Behind Resistant Hypertension
Steve Jackson, PharmD
Jan Basile, MD
Michael J. Bloch, MD, FAHA, FASH, FNLA, FSVM, FACP
The Risk Equation: Combining uACR and eGFR for CV Prediction
Conversations in CV Risk AssessmentThe Risk Equation: Combining uACR and eGFR for CV Prediction
Matthew Sorrentino, MD
Ashish Verma, MBBS
- advertisement
Albuminuria: An Overlooked Red Flag in Cardiovascular Risk
Conversations in CV Risk AssessmentAlbuminuria: An Overlooked Red Flag in Cardiovascular Risk
Matthew Sorrentino, MD
Ashish Verma, MBBS
Hidden High Risk: When BP Control Isn’t Enough in Hypertension
Conversations in CV Risk AssessmentHidden High Risk: When BP Control Isn’t Enough in Hypertension
Gates B. Colbert, MD
Michael E. Hall, MD
Clyde W. Yancy, MD
The Role of CGRPs in First-Line Preventive Migraine Therapy
NeuroFrontiersThe Role of CGRPs in First-Line Preventive Migraine Therapy
Charles Turck, PharmD, BCPS, BCCCP
Richard B. Lipton, MD
Hope O'Brien, MD, MBA, FAHS, FAAN